Toward an integrative view of Optineurin functions

Cell Cycle

Volumn 11, Issue 15, 2012, Pages 2808-2818

  Kachaner, David ^a,b   Génin, Pierre ^a   Laplantine, Emmanuel ^a   Weil, Robert ^a  

^a CNRS   (France)

^b SORBONNE UNIVERSITÉ   (France)

Author keywords

Antiviral and antibacterial host defense; Autophagy; Genetic diseases; Membrane trafficking; Mitosis

Indexed keywords

AQUAPORIN 1; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MEMBRANE PROTEIN; NEUROTROPHIN 4; OPTINEURIN; TRANSFERRIN RECEPTOR; UNCLASSIFIED DRUG;

ACTIN FILAMENT; APOPTOSIS; BINDING KINETICS; BIOACCUMULATION; BIOLOGICAL ACTIVITY; CARBOXY TERMINAL SEQUENCE; ENDOCYTOSIS; ENDOPLASMIC RETICULUM; EXOCYTOSIS; HUMAN; INHIBITION KINETICS; LYSOSOME; MITOSIS; NONHUMAN; PAGET BONE DISEASE; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; PROTEIN SYNTHESIS; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; TRANS GOLGI NETWORK; UBIQUITINATION;

EID: 84864557483     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.20946     Document Type: Review

References (91)

1. Li Y, Kang J, Horwitz MS. Interaction of an adenovirus E3 14.7-kilodalton protein with a novel tumor necrosis factor alpha-inducible cellular protein containing leucine zipper domains. Mol Cell Biol 1998; 18:1601-10; PMID:9488477.
2. Rezaie T, Child A, Hitchings R, Brice G, Miller L, Coca-Prados M, et al. Adult-onset primary open-angle glaucoma caused by mutations in optineurin. Science 2002; 295:1077-9; PMID:11834836; http://dx.doi.org/10.1126/science. 1066901.
3. Ying H, Yue BY. Cellular and molecular biology of optineurin. Int Rev Cell Mol Biol 2012; 294:223-58; PMID:22364875; http://dx.doi.org/10.1016/B978-0- 12-394305-7.00005-7.
4. Rezaie T, Sarfarazi M. Molecular cloning, genomic structure, and protein characterization of mouse optineurin. Genomics 2005; 85:131-8; PMID:15607428; http://dx.doi.org/10.1016/j.ygeno.2004.10.011.
5. Schwamborn K, Weil R, Courtois G, Whiteside ST, Israël A. Phorbol esters and cytokines regulate the expression of the NEMO-related protein, a molecule involved in a NFkappa B-independent pathway. J Biol Chem 2000; 275:22780-9; PMID:10807909; http://dx.doi.org/10.1074/jbc.M001500200.
6. Sudhakar C, Nagabhushana A, Jain N, Swarup G. NFkappaB mediates tumor necrosis factor alpha-induced expression of optineurin, a negative regulator of NFkappaB. PLoS One 2009; 4:e5114; PMID:19340308; http://dx.doi.org/10.1371/ journal.pone.0005114.
7. Chen ZJ. Ubiquitination in signaling to and activation of IKK. Immunol Rev 2012; 246:95-106; PMID:22435549; http://dx.doi.org/10.1111/j.1600-065X.2012. 01108.x.
8. Laplantine E, Fontan E, Chiaravalli J, Lopez T, Lakisic G, Véron M, et al. NEMO specifically recognizes K63-linked poly-ubiquitin chains through a new bipartite ubiquitin-binding domain. EMBO J 2009; 28:2885-95; PMID:19763089; http://dx.doi.org/10.1038/emboj.2009.241.
9. Zhu G, Wu CJ, Zhao Y, Ashwell JD. Optineurin negatively regulates TNFalpha- induced NFkappaB activation by competing with NEMO for ubiquitinated RIP. Curr Biol 2007; 17:1438-43; PMID:17702576; http://dx.doi.org/10.1016/j.cub. 2007.07.041.
10. Journo C, Filipe J, About F, Chevalier SA, Afonso PV, Brady JN, et al. NRP/Optineurin Cooperates with TAX1BP1 to potentiate the activation of NFkappaB by human T-lymphotropic virus type 1 tax protein. PLoS Pathog 2009; 5:e1000521; PMID:19609363; http://dx.doi.org/10.1371/journal.ppat.1000521.
11. Tokunaga F, Iwai K. LUBAC, a novel ubiquitin ligase for linear ubiquitination, is crucial for inflammation and immune responses. Microbes Infect 2012; 14:563-72; http://dx.doi.org/10.1016/j.micinf.2012.01.011; PMID:22309894.
12. Sun SC. CYLD: a tumor suppressor deubiquitinase regulating NFkappaB activation and diverse biological processes. Cell Death Differ 2010; 17:25-34; PMID:19373246; http://dx.doi.org/10.1038/cdd.2009.43.
13. Niu J, Shi Y, Iwai K, Wu ZH. LUBAC regulates NFκB activation upon genotoxic stress by promoting linear ubiquitination of NEMO. EMBO J 2011; 30:3741-53; PMID:21811235; http://dx.doi.org/10.1038/emboj.2011.264.
14. Nagabhushana A, Bansal M, Swarup G. Optineurin is required for CYLD-dependent inhibition of TNFα-induced NFκB activation. PLoS One 2011; 6:e17477; PMID:21408173; http://dx.doi.org/10.1371/journal.pone.0017477.
15. Chalasani ML, Swarup G, Balasubramanian D. Optineurin and its mutants: molecules associated with some forms of glaucoma. Ophthalmic Res 2009; 42:176-84; PMID:19672125; http://dx.doi.org/10.1159/000232400.
16. Shembade N, Harhaj EW. Regulation of NFκB signaling by the A20 deubiquitinase. Cell Mol Immunol 2012; 9:123-30; PMID:22343828; http://dx.doi.org/10.1038/cmi.2011.59.
17. De Marco N, Buono M, Troise F, Diez-Roux G. Optineurin increases cell survival and translocates to the nucleus in a Rab8-dependent manner upon an apoptotic stimulus. J Biol Chem 2006; 281:16147-56; PMID:16569640; http://dx.doi.org/10.1074/jbc.M601467200.
18. Hattula K, Peränen J. FIP-2, a coiled-coil protein, links Huntingtin to Rab8 and modulates cellular morphogenesis. Curr Biol 2000; 10:1603-6; PMID:11137014; http://dx.doi.org/10.1016/S0960-9822(00)00864-2.
19. Faber PW, Barnes GT, Srinidhi J, Chen J, Gusella JF, MacDonald ME. Huntingtin interacts with a family of WW domain proteins. Hum Mol Genet 1998; 7:1463-74; PMID:9700202; http://dx.doi.org/10.1093/hmg/7.9.1463.
20. Harjes P, Wanker EE. The hunt for huntingtin function: interaction partners tell many different stories. Trends Biochem Sci 2003; 28:425-33; PMID:12932731; http://dx.doi.org/10.1016/S0968-0004(03)00168-3.
21. Li SH, Li XJ. Huntingtin-protein interactions and the pathogenesis of Huntington disease. Trends Genet 2004; 20:146-54; PMID:15036808; http://dx.doi.org/10.1016/j.tig.2004.01.008.
22. Truant R, Atwal R, Burtnik A. Hypothesis: Huntingtin may function in membrane association and vesicular trafficking. Biochem Cell Biol 2006; 84:912-7; PMID:17215878; http://dx.doi.org/10.1139/o06-181.
23. Caviston JP, Holzbaur EL. Huntingtin as an essential integrator of intracellular vesicular trafficking. Trends Cell Biol 2009; 19:147-55; PMID:19269181; http://dx.doi.org/10.1016/j.tcb.2009.01.005.
24. del Toro D, Alberch J, Lázaro-Diéguez F, Martín-Ibáñez R, Xifró X, Egea G, et al. Mutant huntingtin impairs post-Golgi trafficking to lysosomes by delocalizing optineurin/Rab8 complex from the Golgi apparatus. Mol Biol Cell 2009; 20:1478-92; PMID:19144827; http://dx.doi.org/10.1091/mbc.E08-07-0726.
25. Caviston JP, Zajac AL, Tokito M, Holzbaur EL. Huntingtin coordinates the dynein-mediated dynamic positioning of endosomes and lysosomes. Mol Biol Cell 2011; 22:478-92; PMID:21169558; http://dx.doi.org/10.1091/mbc.E10-03-0233.
26. Sahlender DA, Roberts RC, Arden SD, Spudich G, Taylor MJ, Luzio JP, et al. Optineurin links myosin VI to the Golgi complex and is involved in Golgi organization and exocytosis. J Cell Biol 2005; 169:285-95; PMID:15837803; http://dx.doi.org/10.1083/jcb.200501162.
27. Au JS, Puri C, Ihrke G, Kendrick-Jones J, Buss F. Myosin VI is required for sorting of AP-1B-dependent cargo to the basolateral domain in polarized MDCK cells. J Cell Biol 2007; 177:103-14; PMID:17403927; http://dx.doi.org/10.1083/ jcb.200608126.
28. Chibalina MV, Poliakov A, Kendrick-Jones J, Buss F. Myosin VI and optineurin are required for polarized EGFR delivery and directed migration. Traffic 2010; 11:1290-303; PMID:20604900; http://dx.doi.org/10.1111/j.1600-0854. 2010.01101.x.
29. Warner CL, Stewart A, Luzio JP, Steel KP, Libby RT, Kendrick-Jones J, et al. Loss of myosin VI reduces secretion and the size of the Golgi in fibroblasts from Snell's waltzer mice. EMBO J 2003; 22:569-79; PMID:12554657; http://dx.doi.org/10.1093/emboj/cdg055.
30. Caviston JP, Ross JL, Antony SM, Tokito M, Holzbaur EL. Huntingtin facilitates dynein/dynactin-mediated vesicle transport. Proc Natl Acad Sci USA 2007; 104:10045-50; PMID:17548833; http://dx.doi.org/10.1073/pnas.0610628104.
31. Caswell P, Norman J. Endocytic transport of integrins during cell migration and invasion. Trends Cell Biol 2008; 18:257-63; PMID:18456497; http://dx.doi.org/10.1016/j.tcb.2008.03.004.
32. Chibalina MV, Roberts RC, Arden SD, Kendrick-Jones J, Buss F. Rab8-optineurin-myosin VI: analysis of interactions and functions in the secretory pathway. Methods Enzymol 2008; 438:11-24; PMID:18413238; http://dx.doi.org/10.1016/S0076-6879(07)38002-6.
33. Sippl C, Bosserhoff AK, Fischer D, Tamm ER. Depletion of optineurin in RGC-5 cells derived from retinal neurons causes apoptosis and reduces the secretion of neurotrophins. Exp Eye Res 2011; 93:669-80; PMID:21896272; http://dx.doi.org/10.1016/j.exer.2011.08.011.
34. Bond LM, Peden AA, Kendrick-Jones J, Sellers JR, Buss F. Myosin VI and its binding partner optineurin are involved in secretory vesicle fusion at the plasma membrane. Mol Biol Cell 2011; 22:54-65; PMID:21148290; http://dx.doi.org/10.1091/mbc.E10-06-0553.
35. Nakhaei P, Genin P, Civas A, Hiscott J. RIG-I-like receptors: sensing and responding to RNA virus infection. Semin Immunol 2009; 21:215-22; PMID:19539500; http://dx.doi.org/10.1016/j.smim.2009.05.001.
36. Kumar H, Kawai T, Akira S. Pathogen recognition by the innate immune system. Int Rev Immunol 2011; 30:16-34; PMID:21235323; http://dx.doi.org/10. 3109/08830185.2010.529976.
37. Savitsky D, Tamura T, Yanai H, Taniguchi T. Regulation of immunity and oncogenesis by the IRF transcription factor family. Cancer Immunol Immunother 2010; 59:489-510; PMID:20049431; http://dx.doi.org/10.1007/s00262-009-0804-6.
38. Uzé G, Schreiber G, Piehler J, Pellegrini S. The receptor of the type I interferon family. Curr Top Microbiol Immunol 2007; 316:71-95; PMID:17969444; http://dx.doi.org/10.1007/978-3-540-71329-6-5.
39. Borden EC, Sen GC, Uze G, Silverman RH, Ransohoff RM, Foster GR, et al. Interferons at age 50: past, current and future impact on biomedicine. Nat Rev Drug Discov 2007; 6:975-90; PMID:18049472; http://dx.doi.org/10.1038/nrd2422.
40. Morton S, Hesson L, Peggie M, Cohen P. Enhanced binding of TBK1 by an optineurin mutant that causes a familial form of primary open angle glaucoma. FEBS Lett 2008; 582:997-1002; PMID:18307994; http://dx.doi.org/10.1016/j. febslet.2008.02.047.
41. Hiscott J. Convergence of the NFkappaB and IRF pathways in the regulation of the innate antiviral response. Cytokine Growth Factor Rev 2007; 18:483-90; PMID:17706453; http://dx.doi.org/10.1016/j.cytogfr.2007.06.002.
42. Mankouri J, Fragkoudis R, Richards KH, Wetherill LF, Harris M, Kohl A, et al. Optineurin negatively regulates the induction of IFNbeta in response to RNA virus infection. PLoS Pathog 2010; 6:e1000778; PMID:20174559; http://dx.doi.org/10.1371/journal.ppat.1000778.
43. Gleason CE, Ordureau A, Gourlay R, Arthur JS, Cohen P. Polyubiquitin binding to optineurin is required for optimal activation of TANK-binding kinase 1 and production of interferon β. J Biol Chem 2011; 286:35663-74; PMID:21862579; http://dx.doi.org/10.1074/jbc.M111.267567.
44. Sakaguchi T, Irie T, Kawabata R, Yoshida A, Maruyama H, Kawakami H. Optineurin with amyotrophic lateral sclerosis-related mutations abrogates inhibition of interferon regulatory factor-3 activation. Neurosci Lett 2011; 505:279-81; PMID:22040667; http://dx.doi.org/10.1016/j.neulet.2011.10.040.
45. Gao L, Coope H, Grant S, Ma A, Ley SC, Harhaj EW. ABIN1 protein cooperates with TAX1BP1 and A20 proteins to inhibit antiviral signaling. J Biol Chem 2011; 286:36592-602; PMID:21885437; http://dx.doi.org/10.1074/jbc.M111. 283762.
46. Radtke AL, Delbridge LM, Balachandran S, Barber GN, O'Riordan MX. TBK1 protects vacuolar integrity during intracellular bacterial infection. PLoS Pathog 2007; 3:e29; PMID:17335348; http://dx.doi.org/10.1371/journal.ppat. 0030029.
47. Radtke AL, O'Riordan MX. Homeostatic maintenance of pathogen-containing vacuoles requires TBK1-dependent regulation of aquaporin-1. Cell Microbiol 2008; 10:2197-207; PMID:18665841; http://dx.doi.org/10.1111/j.1462-5822.2008.01199.x.
48. Haraga A, Ohlson MB, Miller SI. Salmonellae interplay with host cells. Nat Rev Microbiol 2008; 6:53-66; PMID:18026123; http://dx.doi.org/10.1038/ nrmicro1788.
49. Perrin AJ, Jiang X, Birmingham CL, So NS, Brumell JH. Recognition of bacteria in the cytosol of Mammalian cells by the ubiquitin system. Curr Biol 2004; 14:806-11; PMID:15120074; http://dx.doi.org/10.1016/j.cub.2004.04.033.
50. Kraft C, Peter M, Hofmann K. Selective autophagy: ubiquitin-mediated recognition and beyond. Nat Cell Biol 2010; 12:836-41; PMID:20811356; http://dx.doi.org/10.1038/ncb0910-836.
51. Thurston TL, Ryzhakov G, Bloor S, von Muhlinen N, Randow F. The TBK1 adaptor and autophagy receptor NDP52 restricts the proliferation of ubiquitin-coated bacteria. Nat Immunol 2009; 10:1215-21; PMID:19820708; http://dx.doi.org/10.1038/ni.1800.
52. Pankiv S, Clausen TH, Lamark T, Brech A, Bruun JA, Outzen H, et al. p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J Biol Chem 2007; 282:24131-45; PMID:17580304; http://dx.doi.org/10.1074/jbc.M702824200.
53. Cemma M, Kim PK, Brumell JH. The ubiquitin-binding adaptor proteins p62/SQSTM1 and NDP52 are recruited independently to bacteria-associated microdomains to target Salmonella to the autophagy pathway. Autophagy 2011; 7:341-5; PMID:21079414; http://dx.doi.org/10.4161/auto.7.3.14046.
54. Shen X, Ying H, Qiu Y, Park JS, Shyam R, Chi ZL, et al. Processing of optineurin in neuronal cells. J Biol Chem 2011; 286:3618-29; PMID:21059646; http://dx.doi.org/10.1074/jbc.M110.175810.
55. Wild P, Farhan H, McEwan DG, Wagner S, Rogov VV, Brady NR, et al. Phosphorylation of the autophagy receptor optineurin restricts Salmonella growth. Science 2011; 333:228-33; PMID:21617041; http://dx.doi.org/10.1126/ science.1205405.
56. Archambault V, Glover DM. Polo-like kinases: conservation and divergence in their functions and regulation. Nat Rev Mol Cell Biol 2009; 10:265-75; PMID:19305416; http://dx.doi.org/10.1038/nrm2653.
57. Macůrek L, Lindqvist A, Lim D, Lampson MA, Klompmaker R, Freire R, et al. Polo-like kinase-1 is activated by aurora A to promote checkpoint recovery. Nature 2008; 455:119-23; PMID:18615013; http://dx.doi.org/10.1038/ nature07185.
58. Seki A, Coppinger JA, Jang CY, Yates JR, Fang G. Bora and the kinase Aurora a cooperatively activate the kinase Plk1 and control mitotic entry. Science 2008; 320:1655-8; PMID:18566290; http://dx.doi.org/10.1126/science. 1157425.
59. Yamashiro S, Yamakita Y, Totsukawa G, Goto H, Kaibuchi K, Ito M, et al. Myosin phosphatase-targeting subunit 1 regulates mitosis by antagonizing polo-like kinase 1. Dev Cell 2008; 14:787-97; PMID:18477460; http://dx.doi.org/10.1016/j.devcel.2008.02.013.
60. Kachaner D, Filipe J, Laplantine E, Bauch A, Bennett KL, Superti-Furga G, et al. Plk1-dependent phosphorylation of optineurin provides a negative feedback mechanism for mitotic progression. Mol Cell 2012; 45:553-66; PMID:22365832; http://dx.doi.org/10.1016/j.molcel.2011.12.030.
61. Allingham RR, Liu Y, Rhee DJ. The genetics of primary open-angle glaucoma: a review. Exp Eye Res 2009; 88:837-44; PMID:19061886; http://dx.doi.org/10.1016/j.exer.2008.11.003.
62. Liu Y, Allingham RR. Molecular genetics in glaucoma. Exp Eye Res 2011; 93:331-9; PMID:21871452; http://dx.doi.org/10.1016/j.exer.2011.08.007.
63. Chi ZL, Akahori M, Obazawa M, Minami M, Noda T, Nakaya N, et al. Overexpression of optineurin E50K disrupts Rab8 interaction and leads to a progressive retinal degeneration in mice. Hum Mol Genet 2010; 19:2606-15; PMID:20388642; http://dx.doi.org/10.1093/hmg/ddq146.
64. Willoughby CE, Chan LL, Herd S, Billingsley G, Noordeh N, Levin AV, et al. Defining the pathogenicity of optineurin in juvenile open-angle glaucoma. Invest Ophthalmol Vis Sci 2004; 45:3122-30; PMID:15326130; http://dx.doi.org/10. 1167/iovs.04-0107.
65. Park BC, Shen X, Samaraweera M, Yue BY. Studies of optineurin, a glaucoma gene: Golgi fragmentation and cell death from overexpression of wild-type and mutant optineurin in two ocular cell types. Am J Pathol 2006; 169:1976-89; PMID:17148662; http://dx.doi.org/10.2353/ajpath.2006.060400.
66. Kroeber M, Ohlmann A, Russell P, Tamm ER. Transgenic studies on the role of optineurin in the mouse eye. Exp Eye Res 2006; 82:1075-85; PMID:16442524; http://dx.doi.org/10.1016/j.exer.2005.11.004.
67. Meng Q, Lv J, Ge H, Zhang L, Xue F, Zhu Y, et al. Overexpressed mutant optineurin(E50K) induces retinal ganglion cells apoptosis via the mitochondrial pathway. Mol Biol Rep 2012; 39:5867-73; PMID:22422156; http://dx.doi.org/10. 1007/s11033-011-1397-7.
68. Park B, Ying H, Shen X, Park JS, Qiu Y, Shyam R, et al. Impairment of protein trafficking upon overexpression and mutation of optineurin. PLoS One 2010; 5:e11547; PMID:20634958; http://dx.doi.org/10.1371/journal.pone.0011547.
69. Maruyama H, Morino H, Ito H, Izumi Y, Kato H, Watanabe Y, et al. Mutations of optineurin in amyotrophic lateral sclerosis. Nature 2010; 465:223-6; PMID:20428114; http://dx.doi.org/10.1038/nature08971.
70. Tumer Z, Bertelsen B, Gredal O, Magyari M, Nielsen KC, Lucamp, et al. Novel heterozygous nonsense mutation of the OPTN gene segregating in a Danish family with ALS. Neurobiol Aging 2012; 33:208 e1-5.
71. Ito H, Fujita K, Nakamura M, Wate R, Kaneko S, Sasaki S, et al. Optineurin is co-localized with FUS in basophilic inclusions of ALS with FUS mutation and in basophilic inclusion body disease. Acta Neuropathol 2011; 121:555-7; PMID:21327942; http://dx.doi.org/10.1007/s00401-011-0809-z.
72. Millecamps S, Boillée S, Chabrol E, Camu W, Cazeneuve C, Salachas F, et al. Screening of OPTN in French familial amyotrophic lateral sclerosis. Neurobiol Aging 2011; 32:557, e11-3; PMID:21220178; http://dx.doi.org/10.1016/j. neurobiolaging.2010.11.005.
73. Solski JA, Williams KL, Yang S, Nicholson GA, Blair IP. Mutation analysis of the optineurin gene in familial amyotrophic lateral sclerosis. Neurobiol Aging 2012; 33:210, e9-10; PMID:22015311; http://dx.doi.org/10.1016/j. neurobiolaging.2011.09.023.
74. Belzil VV, Daoud H, Desjarlais A, Bouchard JP, DupréN, Camu W, et al. Analysis of OPTN as a causative gene for amyotrophic lateral sclerosis. Neurobiol Aging 2011; 32:555, e13-4; PMID:21074290; http://dx.doi.org/10.1016/j. neurobiolaging.2010.10.001.
75. Ralston SH, Albagha OM. Genetic determinants of Paget disease of bone. Ann N Y Acad Sci 2011; 1240:53-60; PMID:22172040; http://dx.doi.org/10.1111/j. 1749-6632.2011.06228.x.
76. Albagha OM, Visconti MR, Alonso N, Langston AL, Cundy T, Dargie R, et al. Genome-wide association study identifies variants at CSF1, OPTN and TNFRSF11A as genetic risk factors for Paget disease of bone. Nat Genet 2010; 42:520-4; PMID:20436471; http://dx.doi.org/10.1038/ng.562.
77. Stroissnigg H, Repitz M, Miloloza A, Linhartova I, Beug H, Wiche G, et al. FIP-2, an IkappaB-kinase-gamma-related protein, is associated with the Golgi apparatus and translocates to the marginal band during chicken erythroblast differentiation. Exp Cell Res 2002; 278:133-45; PMID:12169269; http://dx.doi.org/10.1006/excr.2002.5567.
78. Nagabhushana A, Chalasani ML, Jain N, Radha V, Rangaraj N, Balasubramanian D, et al. Regulation of endocytic trafficking of transferrin receptor by optineurin and its impairment by a glaucoma-associated mutant. BMC Cell Biol 2010; 11:4; PMID:20085643; http://dx.doi.org/10.1186/1471-2121-11-4.
79. Zucchelli S, Marcuzzi F, Codrich M, Agostoni E, Vilotti S, Biagioli M, et al. Tumor necrosis factor receptor-associated factor 6 (TRAF6) associates with huntingtin protein and promotes its atypical ubiquitination to enhance aggregate formation. J Biol Chem 2011; 286:25108-17; PMID:21454471; http://dx.doi.org/10. 1074/jbc.M110.187591.
80. Anborgh PH, Godin C, Pampillo M, Dhami GK, Dale LB, Cregan SP, et al. Inhibition of metabotropic glutamate receptor signaling by the huntingtin-binding protein optineurin. J Biol Chem 2005; 280:34840-8; PMID:16091361; http://dx.doi.org/10.1074/jbc.M504508200.
81. Gautheron J, Courtois G. "Without Ub I am nothing": NEMO as a multifunctional player in ubiquitin-mediated control of NFkappaB activation. Cell Mol Life Sci 2010; 67:3101-13; PMID:20502939; http://dx.doi.org/10.1007/ s00018-010-0404-9.
82. Eskelinen EL, Prescott AR, Cooper J, Brachmann SM, Wang L, Tang X, et al. Inhibition of autophagy in mitotic animal cells. Traffic 2002; 3:878-93; PMID:12453151; http://dx.doi.org/10.1034/j.1600-0854.2002.31204.x.
83. Colanzi A, Corda D. Mitosis controls the Golgi and the Golgi controls mitosis. Curr Opin Cell Biol 2007; 19:386-93; PMID:17689238; http://dx.doi.org/10.1016/j.ceb.2007.06.002.
84. Vitour D, Dabo S, Ahmadi Pour M, Vilasco M, Vidalain PO, Jacob Y, et al. Polo-like kinase 1 (PLK1) regulates interferon (IFN) induction by MAVS. J Biol Chem 2009; 284:21797-809; PMID:19546225; http://dx.doi.org/10.1074/jbc.M109. 018275.
85. Kuchtey J, Källberg ME, Gelatt KN, Rinkoski T, Komàromy AM, Kuchtey RW. Angiopoietin-like 7 secretion is induced by glaucoma stimuli and its concentration is elevated in glaucomatous aqueous humor. Invest Ophthalmol Vis Sci 2008; 49:3438-48; PMID:18421092; http://dx.doi.org/10.1167/iovs.07-1347.
86. Kwon YH, Fingert JH, Kuehn MH, Alward WL. Primary open-angle glaucoma. N Engl J Med 2009; 360:1113-24; PMID:19279343; http://dx.doi.org/10.1056/ NEJMra0804630.
87. Pellecchia MT, Pivonello R, Monsurrò MR, Trojsi F, Longo K, Piccirillo G, et al. The GH-IGF system in amyotrophic lateral sclerosis: correlations between pituitary GH secretion capacity, insulin-like growth factors and clinical features. Eur J Neurol 2010; 17:666-71; PMID:20002733; http://dx.doi.org/10.1111/j.1468-1331.2009.02896.x.
88. Ralston SH. Pathogenesis of Paget disease of bone. Bone 2008; 43:819-25; PMID:18672105; http://dx.doi.org/10.1016/j.bone.2008.06.015.
89. Moreland RJ, Dresser ME, Rodgers JS, Roe BA, Conaway JW, Conaway RC, et al. Identification of a transcription factor IIIA-interacting protein. Nucleic Acids Res 2000; 28:1986-93; PMID:10756201; http://dx.doi.org/10.1093/nar/28.9. 1986.
90. Li XG, Magenheimer BS, Xia S, Johnson T, Wallace DP, Calvet JP, et al. A tumor necrosis factor-alpha-mediated pathway promoting autosomal dominant polycystic kidney disease. Nat Med 2008; 14:863-8; PMID:18552856; http://dx.doi.org/10.1038/nm1783.
91. Miyamoto-Sato E, Ishizaka M, Horisawa K, Tateyama S, Takashima H, Fuse S, et al. Cell-free cotranslation and selection using in vitro virus for high-throughput analysis of protein-protein interactions and complexes. Genome Res 2005; 15:710-7; PMID:15867431; http://dx.doi.org/10.1101/gr.3510505.